| Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia JC Byrd, JR Brown, S O'brien, JC Barrientos, NE Kay, NM Reddy, ... New England Journal of Medicine 371 (3), 213-223, 2014 | 1919 | 2014 |
| Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations K Stamatopoulos, C Belessi, C Moreno, M Boudjograh, G Guida, ... Blood 109 (1), 259-270, 2007 | 665 | 2007 |
| Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label … C Moreno, R Greil, F Demirkan, A Tedeschi, B Anz, L Larratt, M Simkovic, ... The Lancet Oncology 20 (1), 43-56, 2019 | 615 | 2019 |
| Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label … C Moreno, R Greil, F Demirkan LANCET ONCOLOGY 20 (1), E10-E10, 2019 | 615 | 2019 |
| International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia AC Rawstron, N Villamor, M Ritgen, S Böttcher, P Ghia, JL Zehnder, ... Leukemia 21 (5), 956, 2007 | 486 | 2007 |
| Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis F Murray, N Darzentas, A Hadzidimitriou, G Tobin, M Boudjogra, ... Blood 111 (3), 1524-1533, 2008 | 416 | 2008 |
| ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia P Ghia, K Stamatopoulos, C Belessi, C Moreno, S Stilgenbauer, ... Leukemia 21 (1), 1, 2007 | 303 | 2007 |
| Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents? P Dreger, J Schetelig, N Andersen, P Corradini, M Van Gelder, J Gribben, ... Blood 124 (26), 3841-3849, 2014 | 294 | 2014 |
| Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene P Ghia, K Stamatopoulos, C Belessi, C Moreno, S Stella, G Guida, ... Blood 105 (4), 1678-1685, 2005 | 294 | 2005 |
| A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European … AC Rawstron, C Fazi, A Agathangelidis, N Villamor, R Letestu, ... Leukemia 30 (4), 929, 2016 | 264 | 2016 |
| Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia D Rossi, L Terzi-di-Bergamo, L De Paoli, M Cerri, G Ghilardi, A Chiarenza, ... Blood 126 (16), 1921-1924, 2015 | 263 | 2015 |
| Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL JR Brown, P Hillmen, S O’Brien, JC Barrientos, NM Reddy, SE Coutre, ... Leukemia 32 (1), 83, 2018 | 261 | 2018 |
| Long-term follow-up of the RESONATE™ phase 3 trial of ibrutinib versus ofatumumab JC Byrd, P Hillmen, S O'Brien, JC Barrientos, NM Reddy, S Coutre, ... Blood, blood-2018-08-870238, 2019 | 242 | 2019 |
| Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA … AC Rawstron, KA Kreuzer, A Soosapilla, M Spacek, O Stehlikova, ... Cytometry Part B: Clinical Cytometry 94 (1), 121-128, 2018 | 222 | 2018 |
| ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation J Malcikova, E Tausch, D Rossi, LA Sutton, T Soussi, T Zenz, AP Kater, ... Leukemia, 1, 2018 | 214 | 2018 |
| Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring … AC Rawstron, S Böttcher, R Letestu, N Villamor, C Fazi, H Kartsios, ... Leukemia 27 (1), 142, 2013 | 201 | 2013 |
| New prognostic markers in chronic lymphocytic leukemia C Moreno, E Montserrat Blood reviews 22 (4), 211-219, 2008 | 196 | 2008 |
| Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance C Moreno, K Hodgson, G Ferrer, M Elena, X Filella, A Pereira, T Baumann, ... Blood 116 (23), 4771-4776, 2010 | 195 | 2010 |
| Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience P Abrisqueta, A Pereira, C Rozman, M Aymerich, E Giné, C Moreno, ... Blood 114 (10), 2044-2050, 2009 | 192 | 2009 |
| In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia C Calissano, RN Damle, G Hayes, EJ Murphy, MK Hellerstein, C Moreno, ... Blood 114 (23), 4832-4842, 2009 | 190 | 2009 |
